Table 1.
Test results of the cases.
| Case no. | 1 | 2 | 3 | |||
|---|---|---|---|---|---|---|
| Year | 2013 | 2016 | 2017 | 2020.3.18 | 2020.4.14 | 2019 |
| Age/Sex | 24/F | 27/F | 28/F | NA | 25/F | 50/M |
| Bp/History | 190/120, 6 | 204/144, 6 | 240/160, 10 | NA | 137/97, 2 | 155/110, 10 |
| Serum potassium (mmol/L) | 2.8 | 2.4 | 2.6 | NA | 3.8 | 3.2 |
| 24 h urine potassium excretion (mmol/24L) | NA | 106.29 | 78.05 | NA | 38.9 | 73.89 |
| Serum creatinine (μmol/L) | NA | 60 | 51 | NA | 39 | 57 |
| GFR (mL/min) | NA | 115 | 124 | NA | 177 | 132 |
| 24 h urine protein excretion (mg/24L) | NA | 1148.4 | 342 | NA | 31 | 572 |
| FT3 (pmol/L) | NA | NA | 4.65 | NA | 5.57 | 4.85 |
| FT4 (pmol/L) | NA | NA | 13.72 | NA | 15.51 | 11.79 |
| TSH (μIU/mL) | NA | NA | 1.079 | NA | 1.44 | 10.36 |
| Plasma cortisol (8am) (nmol/L) | NA | NA | 16 | NA | 12.9 | 16.7 |
| ACTH (8am) (pmol/L) | NA | NA | 10.8 | NA | 12.4 | 11.6 |
| Supine PRA (ng/ml/h) | 0.6i | 0.09i | NA | 1.12ii | NA | NA |
| Supine DRC (μIU/mL) | NA | NA | 241.1 | NA | 219.2 | >500 |
| Supine Aldosteron (ng/dl) | 29.7n | 58.1n | 7nnn | 5.88nn | 22.5nnn | 20.4nnn |
| Upright PRA (ng/ml/h) | 0.6i | 0.62i | NA | 1.45ii | NA | NA |
| Upright DRC (μIU/mL) | NA | NA | >500 | NA | 437.2 | >500 |
| Upright Aldosteron (ng/dl) | 39.4n | 31n | 27.4nnn | 8nn | 32.3nnn | 44.8nnn |
Normal range: Serum potassium:3.5-5.5mmol/L; 24h urine potassium excretion: 25.00-100.00mmol/24h; Serum creatinine: 44-115μmol/L; 24h urine protein excretion: 30.0-150.0mg/24h; FT3: 2.43-6.01pmol/L; FT4: 9.01-19.05pmol/L; TSH: μIU/ml; Plasma cortisol(8am): 5.00-25.00ug/dL; ACTH(8am): 0.00-46.00pg/ml; Supine PRA, i:0.05-0.79; ii:0.13-1.74; Upright PRA, i:1.95-3.99; ii:1.45-5; Supine DRC: 2.8-39.9; Upright DRC: 4.4-46.1; Supine Aldosteron, n: 6.0-17.5; nn: 3.0-18.0; nnn: 3.0-23.6; Upright Aldosteron, n: 6.5-30.0; nn: 5.0-31.3; nnn: 3.0-35.3;NA – not available.